Estimation of the HCC markers in animals treated with DENA/CCl4 exhibited significant (p < 0.05) elevation in the AFP, GPC-3, and VEGF compared to their concentrations in the control rats. This evidence concerns the gene VEGFA and hepatocellular carcinoma.